ISAD 2020 (live)

1^st live digital ISAD meeting

September 3rd, 2020 – Online & interactive

VIDEO RECORDING

3.00	Welcome of the Chairs Alain TAÏEB (Bordeaux, France) Kyu-Han KIM (Seoul, South-Korea) Peter SCHMID-GRENDELMEIER (Zurich, Switzerland)
3.05	Introductory lecture AD and COVID-19: lessons from the SECURE-AD registry and beyond Carsten FLOHR (London, United Kingdom)	view ➜
3.20 4.20	SESSION 1 New systemic treatments Moderators: Alain TAÏEB Andreas WOLLENBERG (Munich, Germany)
	Dupilumab: long term single center experience in Japan Yoko KATAOKA (Osaka, Japan)	view ➜
	Dupilumab: paradoxical reactions Dirk Jan HIJNEN (Rotterdam, The Netherlands)	view ➜
	Efficacy and safety of tralokinumab monotherapy in adult patients with moderate-to-severe atopic dermatitis: Results from two 52- week-phase 3 trials (ecztra 1 andecztra 2) Eric L. SIMPSON (Portland, USA)	view ➜
	Abrocitinib treatment in adolescents and adults with moderate-to-severe atopic dermatitis: Early pruritus responses from phase 3 trials jade mono-1 and jade mono-2 Jonathan SILVERBERG (Chicago, USA)	view ➜
	Relationships between clinical response endpoints and other outcome measures: data from the updacitinib atopic dermatitis phase 2B trial Kristian REICH (Hamburg, Germany)	view ➜
	Panel Discussion Moderators, Speakers, Amy S. PALLER (Chicago, USA)  / Lisa BECK (Rochester, USA)  / Emma GUTTMAN (New York, USA) / Kyu-Han KIM
4.20	COFFEE BREAK Bring your own 😉
4.30 5.25	SESSION 2 New fields in AD: big data mining, AD in sub-Saharan Africa, neuroinflammation Moderators: Peter SCHMID-GRENDELMEIER Johannes RING (Munich, Germany) Roberto TAKAOKA (Sao Paulo, Brasil) Norito KATOH (Kyoto, Japan)
	Korean National Health insurance AD data Jiyoung AHN (Seoul, South Korea)	view ➜
	Teledermatology and AD in Subsaharan Africa Garba MAHAMADOU (Lomé, Togo)	view ➜
	Atopic dermatitis in Antananarivo, Madagascar Benja RAPELANORO (Antanarivo, Madagascar)	view ➜
	Neuroimmunology of atopic dermatitis Martin STEINHOFF (Doha, QATAR)	view ➜
	Panel Discussion Speakers and moderators together
5.25	SUMMARY / FINAL REMARKS Alain TAÏEB

---

Dear colleagues, dear friends,

I first have a thought for all of you who are at the forefront of your hospital to manage SARS-Cov 2 patients, dermatology and immunology are very important in this context.

For this year where new advances in AD therapy are eagerly awaited, we are missing our carefully planned Rajka Symposium by Kyu-Han KIM and colleagues from Seoul. The new date in the same place is now scheduled for April 2021 (18-20), more details to be announced in the coming months.

Because of this long interval, the ISAD executive committee decided jointly with the Seoul LOC to organize a global event, and perhaps a new era of communication within our AD community. Digital platforms are evolving at a rapid pace to meet the needs of professionals, particularly in the field of biomedical sciences.

We have chosen a digital solution that makes possible a short but live global meeting, allowing discussion, at 03:00 pm CEST on September 3rd, corresponding to Eastern Daylight Time 9:00 am – 11:30 am Pacific Daylight Time 6:00-8:30 am, Seoul Tokyo time 10:00 pm – 0:30 am.

Please mark this date / time on your calendar, more information will follow soon on a very exciting program.

Best wishes,